AIDS WEEKLY Plus - February - 1999Important note: Information in this article was accurate in February 1999. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

Conference Coverage: Wasting Tied to HIV Stimulation of Myostatin

AIDSWEEKLY Plus; Monday, February 8, 1999
Daniel J. DeNoon, Senior Editor


The key to AIDS wasting may at last have been found.

Wasting of lean muscle mass is such a central feature of HIV disease that AIDS is known as "slim disease" in parts of Africa.

Now researchers at Washington University Medical School, St. Louis, Missouri, have found that levels of HIV replication are positively correlated with elevated production of myostatin.

"Our findings suggest that high plasma viremia is associated with suppressed muscle protein synthesis and overexpression of myostatin," reported K.E. Yarasheski in a presentation to the 6th Conference on Retroviruses and Opportunistic Infections, held January 31-February 4, 1999, in Chicago, Illinois.

"We propose that elevated plasma viremia might indirectly mediate AIDS muscle wasting by augmenting myostatin expression which may inhibit the rate of muscle protein synthesis."

Myostatin is the growth and differentiation factor known as GDF-8. The gene for this protein has recently been shown to be a member of the tumor growth factor beta (TGF-(beta)) superfamily.

Knockout mice that do not express the myostatin gene grow muscles two to three times larger than normal mice.

Yarasheski et al. compared plasma myostatin concentrations in 10 men with asymptomatic HIV infection, in six men with AIDS-associated wasting, and in six seronegative controls.

The researchers found a direct positive correlation between plasma HIV RNA and myostatin levels (R(2)=0.28, P=0.05).

Related abstract

990208
AW990206


Copyright © 1999 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990, 2000. AEGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ĘGIS, or the party credited as the provider of the content.